Chemistry, systems and methods of translocation of a polymer through a nanopore
US-2017343558-A1 · Nov 30, 2017 · US
US2026072009A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2026072009-A1 |
| Application number | US-202519396980-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 21, 2025 |
| Priority date | Dec 2, 2019 |
| Publication date | Mar 12, 2026 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are methods of characterising a target polypeptide as it moves with respect to a nanopore. Also provided are related kits, systems and apparatuses for carrying out such methods.
Opening claim text (preview).
What is claimed: 1 . A method of controlling movement of a target polypeptide through a transmembrane protein pore, the method comprising: (i) holding at least a portion of the target polypeptide in a linearized form in the transmembrane protein pore under electro-osmotic force conditions; (ii) controlling the movement of the target polypeptide through the transmembrane protein pore under an applied electrical potential; and (iii) taking one or more electrical measurements as the target polypeptide moves through the transmembrane protein pore. 2 . The method of claim 1 , wherein the electro-osmotic force conditions comprise an unbalanced flow of cations and anions through the transmembrane protein pore under the applied electrical potential. 3 . The method of claim 1 , wherein the transmembrane protein pore comprises one or more amino acid additions, substitutions, or deletions relative to an unmodified transmembrane protein pore. 4 . The method of claim 1 , wherein the electro-osmotic force conditions comprise asymmetric salt conditions across the transmembrane pore. 5 . The method of claim 1 , wherein the method is carried out in the presence of guanidine HCl. 6 . The method of claim 1 , wherein the target polypeptide is conjugated to a leader comprising a charged polymer. 7 . The method of claim 1 , wherein the target polypeptide is conjugated to a leader comprising a polynucleotide. 8 . The method of claim 1 , wherein the transmembrane protein pore is derived from MspA, MspB, MspC, MspD, α-hemolysin, lysenin, CsgG, OmpF, OmpG, NalP, ClyA, Sp1, or FraC. 9 . The method of claim 1 , wherein the transmembrane protein pore is derived from CsgG. 10 . The method of claim 1 , wherein the transmembrane protein pore is derived from MspA. 11 . The method of claim 1 , wherein taking the one or more electrical measurements comprises measuring an ion current flow through the transmembrane protein pore.
Labels used in chemical analysis of biological material · CPC title
Sequencing of polypeptides · CPC title
Marker; Tag · CPC title
DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title
Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.